Chronic elevation of PTH, even in the absence of hypercalcemia, may increase the risk of cortical bone loss and osteoporosis, as observed in normocalcemic primary hyperparathyroidism [24, 35]. The gene discussed is PTH; the disease is hypercalcemia disease.